From: Evidence-based sizing of non-inferiority trials using decision models
Strategy | 10y cumulative incidence | Life-years (per 1000 pt) | QALYs lost due to surveillance (per 1000 pt) | QALYs lost due to complications (per 1000 pt) | QALYs lost due to treatment (per 1000 pt) | QALYs (per 1000 pt) | Difference in QALYs (per 1000 pt) |
---|---|---|---|---|---|---|---|
5-yearly surveillance | 1.0% | 22,424 | 26.3 | 0.3 | 54.1 | 22,343.2 | Reference Strategy |
10-yearly surveillance | 1.0% | 22,424 | 18.0 | 0.2 | 54.1 | 22,351.5 | 8.3 |
10-yearly surveillance | 1.5% | 22,412 | 18.1 | 0.2 | 55.8 | 22,338.1 | −5.1 |
10-yearly surveillance | 1.3% | 22,419 | 18.0 | 0.2 | 49.8a | 22,351.0 | 8.1 |
10-yearly surveillance | 1.42% | 22,415 | 18.1 | 0.2 | 53.5a | 22,343.1 | 0.0 |